A Study of OLR in First-line Treatment of Mantle Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Mantle Cell Lymphoma
Related studies linked through entity extraction aliases.
Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
- Status
- COMPLETED
- Phase
- NA
Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
B-cell Chronic Lymphoid Malignancies Markers
- Status
- UNKNOWN
- Phase
- N/A
Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- NA
Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
- Status
- COMPLETED
- Phase
- N/A
Avo In R/R And Previously Untreated MCL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Parsaclisib, a PI3Kδ Inhibitor, in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
- Status
- RECRUITING
- Phase
- PHASE1